Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

FRA/U9O0 stock hub

FRA/U9O0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/U9O0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5M

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/U9O0

In the news

Latest news · FRA/U9O0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/E15.5

P25 16.4P50 20.9P75 30.4

ROE17.2

P25 -6.7P50 8.5P75 17.2

ROIC4.7

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/U9O0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

AUD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	DE
Enterprise value	EUR 1.6M
Exchange	Frankfurt Stock Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Medical - Healthcare Information Services
Isin	AU0000146961
Last refreshed	2026-05-10
Market cap	EUR 1.5M
Price	EUR 0.04
Price currency	EUR
Sector	Healthcare
Sic	7370
Symbol	fra/U9O0
Website	https://www.oakridgeint.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.47%
EV Earnings	16.42x
EV/EBIT	26.27x
EV/EBITDA	11.86x
EV/FCF	-8.85x
EV/Sales	0.83x
FCF yield	-12%
P/B ratio	2.45x
P/E ratio	15.46x
P/S ratio	0.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.15%
EBITDA Margin	3.75%
Gross margin	36.71%
Gross Profit	EUR 650,226
Gross Profit Growth	35.14%
Gross Profit Growth Q	79.21%
Gross Profit Growth3 Y	75.65%
Gross Profit Growth5 Y	24.24%
Net Income	EUR 96,812
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	2.94%
Profit Margin	5.47%
ROA	3.29
Roa5y	-6.06
ROCE	8.86
ROE	17.23
Roe5y	-9.27
ROIC	4.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-40.08%
Cagr1y	16.23%
Cagr3y	8.68%
Cagr5y	-33.07%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	60.88x
Revenue Growth Q	61.91x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	38.36x
Revenue Growth5 Y	19.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.67
Assets	EUR 1.2M
Cash	EUR 121,101
Current Assets	EUR 1.2M
Current Liabilities	EUR 615,575
Debt	EUR 207,289
Debt EBITDA	EUR 1.68
Debt Equity	EUR 0.34
Debt FCF	EUR -1.15
Equity	EUR 610,418
Interest Coverage	15.87
Liabilities	EUR 588,584
Long Term Assets	EUR 828
Long Term Liabilities	EUR -26,991
Net Cash	EUR -86,188
Net Cash By Market Cap	EUR -5.76
Net Debt EBITDA	EUR 1.3
Net Debt Equity	EUR 0.14
Tangible Book Value	EUR 610,418
Tangible Book Value Per Share	EUR 0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.95
Inventory Turnover	4.38
Net Working Capital	EUR 617,120
Quick ratio	0.93
Working Capital	EUR 538,297
Working Capital Turnover	EUR 2.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.4%
1Y total return	16.22%
200-day SMA	0.03
3Y total return	28.36%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-86.56%
All Time High	26
All Time High Change	-99.83%
All Time High Date	2016-06-01
All Time Low	0.02
All Time Low Change	145.71%
All Time Low Date	2025-04-07
ATR	0
Ch YTD	38.71
High	0.04
High52	0.05
High52 Date	2026-05-04
High52ch	-7.53%
Low	0.04
Low52	0.02
Low52 Date	2025-08-21
Low52ch	82.98%
Ma50ch	31.1%
Price vs 200-day SMA	27.6%
RSI	62.02
RSI Monthly	51.27
RSI Weekly	63.98
Sharpe ratio	0.67x
Sortino ratio	1.13
Total Return	-14.56%
Tr YTD	38.71
Tr1m	53.57%
Tr1w	-7.53%
Tr3m	21.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 55,837
Operating margin	3.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,997,585%
Net Borrowing	69,078.6
Shares Insiders	50.87%
Shares Qo Q	-0.32%
Shares Yo Y	14.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -179,574
Average Volume	0x
Bv Per Share	0.02
CAPEX	EUR -16,665
Ch10y	-99.55
Ch1m	53.57
Ch1w	-7.53
Ch1y	16.22
Ch3m	21.13
Ch3y	28.36
Ch5y	-86.56
Ch6m	21.13
Change	2.38%
Change From Open	0
Close	0.04
Days Gap	2.38
Depreciation Amortization	11,370.6
Earnings Date	2026-05-12
EBIT	EUR 55,837
EBITDA	EUR 66,342
EPS	EUR 0
F Score	4
FCF	EUR -179,574
FCF EV Yield	-11.3x
Financing CF	63,826
Fiscal Year End	June
Graham Number	0.03314
Graham Upside	-22.93
Income Tax	EUR -44,785
Investing CF	-16,665
Is Primary Listing	0
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Last Split Date	2021-11-30
Last Split Type	Reverse
Ma150	0.03
Ma150ch	24.64%
Ma20	0.04
Ma20ch	21.47%
Net CF	-115,748
Next Earnings Date	2026-05-12
Open	0.04
Ppne	99,504.8
Price Date	2026-05-08
Price EBITDA	EUR 22.55
Ptbv Ratio	2.45
Relative Volume	3.4x
Revenue	1,771,131x
Tax By Revenue	-2.53x
Tr6m	21.13%
Z Score	-15.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/U9O0 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/U9O0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/U9O0?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+50.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+14.6%

Negative means the company is buying back shares.

Technical

FRA/U9O0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.0

Neutral momentum band

Price vs 200-day MA

+27.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/U9O0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/U9O0 stock rating?

fra/U9O0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/U9O0 analysis?

The full report lives at /stocks/fra/U9O0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/U9O0?

The latest report frames fra/U9O0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/U9O0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.